These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6128635)

  • 41. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interindividual variation in carcinogen metabolism and bladder cancer risk.
    Vineis P; Ronco G
    Environ Health Perspect; 1992 Nov; 98():95-9. PubMed ID: 1486869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
    Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p21 and CK2 interaction-mediated HDAC2 phosphorylation modulates KLF4 acetylation to regulate bladder cancer cell proliferation.
    Jia ZM; Ai X; Teng JF; Wang YP; Wang BJ; Zhang X
    Tumour Biol; 2016 Jun; 37(6):8293-304. PubMed ID: 26729194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meta-analysis of the relationship between slow acetylation of N-acetyl transferase 2 and the risk of bladder cancer.
    An Y; Li H; Wang KJ; Liu XH; Qiu MX; Liao Y; Huang JL; Wang XS
    Genet Mol Res; 2015 Dec; 14(4):16896-904. PubMed ID: 26681036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arylamines and bladder cancer causality: application of conceptual and operational criteria.
    Lower GM
    Clin Pharmacol Ther; 1983 Aug; 34(2):129-35. PubMed ID: 6872405
    [No Abstract]   [Full Text] [Related]  

  • 48. Hypothesis: coffee consumption, N-acetyltransferase phenotype, and cancer.
    Vineis P
    J Natl Cancer Inst; 1993 Jun; 85(12):1004-5. PubMed ID: 8496974
    [No Abstract]   [Full Text] [Related]  

  • 49. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
    Peters JH; Gordon GR; Lin E; Green CE; Tyson CA
    Anticancer Res; 1990; 10(1):225-9. PubMed ID: 2334132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-Aminofluorene-DNA adducts in mouse urinary bladder: effect of age, sex and acetylator phenotype.
    Levy GN; Weber WW
    Carcinogenesis; 1992 Feb; 13(2):159-64. PubMed ID: 1740004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
    Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of acetylator status to isoniazid toxicity, lupus erythematosus, and bladder cancer.
    Weber WW; Hein DW; Litwin A; Lower GM
    Fed Proc; 1983 Nov; 42(14):3086-97. PubMed ID: 6628700
    [No Abstract]   [Full Text] [Related]  

  • 54. Acetylation.
    Weber WW
    Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Microsatellite markers and methylation of promoters of tumour suppressor genes in bladder cancer].
    Collin-Chavagnac D; Descotes F; Billon S; Adams M; Decaussin M; Piaton E; Rodriguez-Lafrasse C; Ruffion A
    Ann Pathol; 2010 Nov; 30(5 Suppl 1):119-20. PubMed ID: 21055568
    [No Abstract]   [Full Text] [Related]  

  • 56. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model.
    Hein DW; Rustan TD; Bucher KD; Furman EJ; Martin WJ
    J Pharmacol Exp Ther; 1991 Jul; 258(1):232-6. PubMed ID: 2072298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers.
    Rothman N; Bhatnagar VK; Hayes RB; Zenser TV; Kashyap SK; Butler MA; Bell DA; Lakshmi V; Jaeger M; Kashyap R; Hirvonen A; Schulte PA; Dosemeci M; Hsu F; Parikh DJ; Davis BB; Talaska G
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5084-9. PubMed ID: 8643532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultra-slow N-Acetyltransferase 2 Is Associated with Recurrence-free Time in Bladder Cancer Patients.
    Selinski S; Gerullis H; Otto T; Roth E; Volkert F; Ovsiannikov D; Salem J; Moormann O; Geis BC; Niedner H; Blaszkewicz M; Hengstler JG; Golka K
    Eur Urol; 2017 Jun; 71(6):994-995. PubMed ID: 28040354
    [No Abstract]   [Full Text] [Related]  

  • 59. Diagnostic and Prognostic Markers in Bladder Cancer.
    Ku JH; Kim WJ; Lerner SP; Chun F; Kluth LA
    Dis Markers; 2016; 2016():2425091. PubMed ID: 27795607
    [No Abstract]   [Full Text] [Related]  

  • 60. Acetylator status, drug metabolism and disease.
    Pande JN; Pande A; Singh SP
    Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.